Profile
Corporate information
Registration country
Registration country
Investment activity status
Not investing
Company type
Singapore-based cancer therapeutics company which, focuses on the discovery, research, and clinical development of small molecule drugs.Funding
Funding rounds
Venture USD 5,000,000
USD 5,000,000 (23 Sep 2010)
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
Mitsui & Co Global Investment Inc | United States |
Other USD 112,500,000
USD 112,500,000 (21 Jan 2009)
Global exclusive license to develop and commercialize multi-kinase inhibitor SB1317.
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
Tragara Pharmaceuticals Inc | Development of proprietary drugs for the treatment of cancer and inflammation-related disorders. | United States |
Series B USD 26,000,000
USD 26,000,000 (20 Oct 2008)
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
Aravis Venture Associates AG | Switzerland | Led the round. | |
|
Bio*One Capital Pte Ltd | Singapore | ||
|
|
Lacuna LLC | United States | ||
|
ZKB Start-up Finance | Switzerland |
Cap Table
Current and past shareholders
| Investor | Contacts | Round | |
|---|---|---|---|
|
|
Aravis Venture Associates AG |
+41 (61) 466-1000 |
Series B |
|
|
Bio*One Capital Pte Ltd |
Series B | |
|
|
Lacuna LLC |
+1 (303) 447-1700 |
Series B |
|
|
Mitsui & Co Global Investment Inc |
Venture | |
|
Novartis Services Inc |
+1 (617) 871-3536 |
N/A |
|
|
Tragara Pharmaceuticals Inc Development of proprietary drugs for the treatment of cancer and inflammation-related disorders. |
+1 (858) 350-6900 |
Other |
|
|
ZKB Start-up Finance |
Series B |